Trademark: 85684241
Word
FYDALIR
Status
Dead
Status Code
606
Status Date
Monday, September 8, 2014
Serial Number
85684241
Mark Type
4000
Filing Date
Monday, July 23, 2012
Published for Opposition
Tuesday, June 11, 2013
Abandoned Date
Monday, September 8, 2014

Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use, namely, for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Trademark Events
Sep 8, 2014
Abandonment Notice Mailed - No Use Statement Filed
Sep 8, 2014
Abandonment - No Use Statement Filed
Mar 4, 2014
Notice Of Approval Of Extension Request E-Mailed
Mar 3, 2014
Extension 1 Granted
Feb 6, 2014
Extension 1 Filed
Mar 2, 2014
Case Assigned To Intent To Use Paralegal
Feb 6, 2014
Teas Extension Received
Aug 6, 2013
Noa E-Mailed - Sou Required From Applicant
Jun 11, 2013
Official Gazette Publication Confirmation E-Mailed
Jun 11, 2013
Published For Opposition
May 22, 2013
Notification Of Notice Of Publication E-Mailed
May 6, 2013
Law Office Publication Review Completed
May 5, 2013
Approved For Pub - Principal Register
May 3, 2013
Teas/Email Correspondence Entered
May 2, 2013
Correspondence Received In Law Office
May 3, 2013
Assigned To Lie
May 2, 2013
Teas Response To Office Action Received
Mar 12, 2013
Teas Change Of Correspondence Received
Nov 16, 2012
Notification Of Non-Final Action E-Mailed
Nov 16, 2012
Non-Final Action E-Mailed
Nov 16, 2012
Non-Final Action Written
Nov 13, 2012
Assigned To Examiner
Jul 30, 2012
New Application Office Supplied Data Entered In Tram
Jul 26, 2012
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24